Nikko Brix
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in ⓘ
- Oncology 6
- Cancer Cells and Metastasis 3
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Kirsten Lauber (13 shared papers)Claus Belka (10 shared papers)Roman Hennel (6 shared papers)Daniel Samaga (2 shared papers)Horst Zitzelsberger (3 shared papers)Anne Ernst (5 shared papers)Michael Orth (4 shared papers)Christoph A. Reichel (3 shared papers)
- Journals
- Radiation Oncology (4 papers)Frontiers in Oncology (1 paper)Cancer Letters (1 paper)Oncotarget (1 paper)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Nikko Brix
12 papers receiving 497 citations
Peers
Comparison fields: 5 of 76
- Oncology 244
- Immunology 132
- Cancer Research 58
- Pulmonary and Respiratory Medicine 109
- Radiology, Nuclear Medicine and Imaging 72
Countries citing papers authored by Nikko Brix
This map shows the geographic impact of Nikko Brix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikko Brix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikko Brix more than expected).
Fields of papers citing papers by Nikko Brix
This network shows the impact of papers produced by Nikko Brix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikko Brix. The network helps show where Nikko Brix may publish in the future.
Co-authors
The 25 scholars most cited alongside Nikko Brix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 156 | |
| 2 | 2018 | 105 | |
| 3 | 2021 | 74 | |
| 4 | 2015 | 56 | |
| 5 | 2020 | 39 | |
| 6 | 2014 | 35 | |
| 7 | 2016 | 20 | |
| 8 | 2022 | 7 | |
| 9 | 2020 | 6 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2021 | 0 |
About Nikko Brix
Nikko Brix is a scholar working on Otorhinolaryngology, Oncology, Immunology, Genetics and Cell Biology, having authored 13 papers that have together received 503 indexed citations. Recurring topics across this work include Endoplasmic Reticulum Stress and Disease (3 papers), Cancer Cells and Metastasis (3 papers), Effects of Radiation Exposure (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Heat shock proteins research (3 papers), Immunotherapy and Immune Responses (2 papers), Ferroptosis and cancer prognosis (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (244 citations), Immunology (132 citations), Cancer Research (58 citations), Pulmonary and Respiratory Medicine (109 citations) and Radiology, Nuclear Medicine and Imaging (72 citations). Nikko Brix has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Kirsten Lauber, Claus Belka, Roman Hennel, Daniel Samaga, Horst Zitzelsberger, Anne Ernst, Michael Orth, Christoph A. Reichel, Gabriele Zuchtriegel and Susanne Bierschenk. Their work appears in journals such as Radiation Oncology, Frontiers in Oncology, Cancer Letters, Oncotarget and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.